US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalD
DXR
DAXOR CORP
9.23
0.48+5.49%Closed16:00 11/12 EST
OPEN/PREV CLOSE8.88/8.75
TODAY RANGE8.53-9.26
VOL23.62K
MARKET CAP44.67M
52 WEEK RANGE7.11-10.04
AVG VOL (3M)7.41K
% TURNOVER0.49%
TURNOVER--
P/E (TTM)27.34
% RANGE8.26%
EPS(TTM)0.3376
P/E(FORWARD)9.23
P/B1.368
BVPS6.75
DIVIDEND--
P/S271.47
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP19.43M
SHARES OUTSTANDING4.84M
NEXT EARNINGS--
FREE FLOAT2.10M
LOT SIZE1
EX-DIV DATE01/05/2018
News
Press Releases
Financial Reports
Profile
TipRanks·10/09 12:05
Daxor’s BVA-100 diagnostic featured at MedAxiom CV Transforum Fall ’24
TipRanks·09/27 21:10
Daxor to resubmit 510(k) application for blood volume analyzer platform
Reuters·09/27 21:00
DAXOR CORP - TO WITHDRAW DUAL 510(K)/CLIA-WAIVER APPLICATION
Reuters·09/27 21:00
DAXOR CORP - TO PURSUE SEPARATE CLIA-WAIVER APPLICATION
Dow Jones·09/09 10:06
Daxor Is Maintained at Buy by Ascendiant Capital
Dow Jones·09/09 10:06
Daxor Price Target Raised to $24.75/Share From $24.50 by Ascendiant Capital
Benzinga·09/09 09:57
Ascendiant Capital Maintains Buy on Daxor, Raises Price Target to $24.75
Reuters·08/06 12:00
DAXOR CORP - AWARDED $1.9M TWO-YEAR CONTRACT FROM USAF
Seeking Alpha·06/05 12:11
Daxor names John Jefferies as chief medical officer
Dow Jones·05/13 08:56
Investor's Confidence in German Economy Is Growing -- Market Talk
TipRanks·04/15 09:17
Daxor’s Promising Growth and Innovation Outlook Merit a Buy Rating
Same Industry
Name/Symbol
Change%
Price